Intrommune Therapeutics obtained world-wide rights from Allovate Therapeutics to develop the OMIT platform for the treatment of food allergies (including
peanut allergy).
[USA], July 22 (ANI): An early introduction to peanuts in infant's diet can reduce the risk of
peanut allergy, recent findings suggest.
The Institute for Clinical and Economic Review on Wednesday released a final report on emerging desensitization treatments for
peanut allergy and compared the clinical effectiveness and value of Aimmune's AR101, DBV Technologies' (DBVT) Viaskin and non-commercialized oral immunotherapy for treatment of
peanut allergy, Moussatos tells investors in a research note.
Vedanta Biosciences, a subsidiary of PureTech Health, has enrolled its first patient in the Phase 1b/2 clinical study of VE416 in adults and adolescents with a history of
peanut allergy, it was reported yesterday.
These results build on the earlier ones from the Learning Early About
Peanut Allergy (LEAP) study which demonstrated that infants who were at a high-risk of developing
peanut allergy but consumed a peanut?containing snack throughout the study were prevented from later developing a
peanut allergy.
Immunotherapy is showing success in treating a condition that is both dangerous to millions and on the rise:
peanut allergy.
The estimated prevalence of egg allergy is 0.5-8.9% in early childhood, [1-6] while
peanut allergy prevalence has a wide range according to geographical area, generally ~0.5 - 2.0%, but as high as 5.9% in some countries such as Sweden.
It always seemed to me that there was a lesson to be learned from African babies who are weaned on peanuts and never get
peanut allergy. Does this early weaning - an early exposure of the immune system to peanuts - teach it NOT to see them as causing allergy?
Danone North America has recalled 3,521 cases of Greek yogurt for a possible
peanut allergy risk.
However, the drug "is not a quick fix, and it doesn't mean people with
peanut allergy will be able to eat peanuts whenever they want", the researchers stressed, in the paper published in the New England Journal of Medicine.
PEANUT allergy sufferers have been given new hope following the results of a landmark study.
The PALISADE study recruited nearly 500 children aged four to 17 from the US and Europe to take part in the largest-ever
peanut allergy treatment trial.